XTNT logo

Xtant Medical Holdings (XTNT)

Profile

Full Name

Xtant Medical Holdings, Inc.

Ticker Symbol

XTNT

Exchange

NYSE American

Sector

Healthcare

Industry

Medical Devices

Country

United States

IPO

July 1, 2010

Indexes

Not included

Website

http://xtantmedical.com

Employees

217

Key Details

Price

$0.40(+1.28%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$117.27M(+28.44% YoY)

Annual EPS

-$0.12(-1300.00% YoY)

PE ratio

-

Next earnings date

May 15, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$0.40
XTNT price is $0.40

30-Day Relative Volume

7.28
XTNT 30-day relative volume is 7.28

Price Performance

Price Today change

+1.28%
XTNT price is up +1.28% today

Price YTD change

-10.23%
XTNT price is down -10.23% since January 1st

Price 1-year change

-50%
XTNT price is down -50% year-on-year

Price 3-year change

-42.75%
XTNT price is down -42.75% over the past 3 years

Price Range

Price All-time high

$1080.00
XTNT price is currently -99.96% below its historical high of $1080.00

Price 3-year low

$0.33
XTNT price is currently +19.70% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$54.93M
XTNT market capitalization is $54.93 million

Market cap 3-year change

-8.82%
XTNT market capitalization is down -8.82% over the past 3 years

Market cap All-time high

$375.44M
XTNT market capitalization is currently -85.37% below its historical high of $375.44 million

Market cap sector rank

39.64%
XTNT market capitalization is higher than 39.64% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+6.8%
XTNT shares outstanding is up +6.8% year-on-year

Shares Outstanding 3-Year Change

+59.27%
XTNT shares outstanding is up +59.27% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.90
XTNT beta is 0.90

200-day SMA

$0.55
XTNT price is currently -28.22% below its 200-day simple moving average

50-day SMA

$0.50
XTNT price is currently -20.56% below its 50-day simple moving average

RSI

40.11
XTNT 14-day relative strength index is 40.11

Volume

7.28
XTNT 30-day relative volume is 7.28

ATR

$0.05
XTNT average true range is $0.05

10-day Historical Volatility

102.36%
XTNT 10-day historical volatility is 102.36%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$117.27M
XTNT annual revenue is $117.27 million

Revenue Analysts estimate

$127.15M
XTNT annual revenue is currently -7.77% lower than the consensus analysts' forecast

Revenue 1-year change

+28.44%
XTNT annual revenue is up +28.44% year-on-year

Revenue Sector rank

57.77%
XTNT annual revenue is higher than 57.77% of companies in Healthcare sector

EPS

EPS

-$0.12
XTNT annual earnings per share is -$0.12

EPS Analysts estimate

-$0.05
XTNT annual earnings per share is currently +140.00% higher than the consensus analysts' forecast

EPS 1-year change

-1300%
XTNT annual earnings per share is down -1300% year-on-year

EPS Sector rank

79.95%
XTNT annual earnings per share is higher than 79.95% of companies in Healthcare sector

Profit

Gross profit

$68.22M
XTNT annual gross profit is $68.22 million

Gross margin

58.17%
XTNT annual gross profit margin is 58.17%

Operating profit

-$12.07M
XTNT annual operating income is -$12.07 million

Operating margin

-10.30%
XTNT annual operating profit margin is -10.30%

Net income

-$16.45M
XTNT annual net profit is -$16.45 million

Net margin

-14.03%
XTNT annual net profit margin is -14.03%

Expenses

Total expenses

$129.34M
XTNT annual total expenses is $129.34 million

Operating expenses

$80.29M
XTNT annual total operating expenses is $80.29 million

Cost of goods sold

$49.05M
XTNT annual cost of goods sold is $49.05 million

Selling, general & administrative expenses

$77.91M
XTNT annual SGA is $77.91 million

Depreciation and amortization

$4.22M
XTNT annual depreciation & amortization is $4.22 million

Interest expense

$4.16M
XTNT annual interest expense is $4.16 million

Income tax

$187.00K
XTNT annual income tax is $187.00 thousand

EBIT & EBITDA

EBIT

-$12.10M
XTNT annual earnings before interest & taxes is -$12.10 million

EBITDA

-$7.88M
XTNT annual EBITDA is -$7.88 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$93.84M
XTNT annual total assets is $93.84 million

Non current assets

$26.72M
XTNT annual long term assets is $26.72 million

Current assets

$67.12M
XTNT annual total current assets is $67.12 million

Cash and cash equivalents

$6.20M
XTNT annual cash & cash equivalents is $6.20 million

Accounts receivable

$20.66M
XTNT annual accounts receivable is $20.66 million

Inventory

$38.63M
XTNT annual inventory is $38.63 million

Liabilities

Total liabilities

$50.87M
XTNT annual total liabilities is $50.87 million

Long term liabilities

$22.29M
XTNT annual total long term liabilities is $22.29 million

Current liabilities

$28.58M
XTNT annual total current liabilities is $28.58 million

Accounts payable

$7.92M
XTNT annual accounts payable is $7.92 million

Debt

Total debt

$35.14M
XTNT annual total debt is $35.14 million

Total debt 1-year change

+49.17%
XTNT annual total debt is up +49.17% year-on-year

Long term debt

$22.25M
XTNT annual long term debt is $22.25 million

Short term debt

$12.89M
XTNT annual short term debt is $12.89 million

Equity & Capital

Shareholders equity

$42.96M
XTNT annual stockholders equity is $42.96 million

Book value

$42.96M
XTNT annual book value is $42.96 million

Retained earnings

-$259.46M
XTNT annual retained earnings is -$259.46 million

Working capital

$38.53M
XTNT annual working capital is $38.53 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$11.90M
XTNT annual cash flow from operations is -$11.90 million

Cash from operations 1-year change

-25.02%
XTNT annual cash flow from operations is down -25.02% year-on-year

Cash from investing

-$3.73M
XTNT annual cash flow from investing activities is -$3.73 million

Cash from investing 1-year change

+84.95%
XTNT annual cash flow from investing activities is up +84.95% year-on-year

Cash from financing

$16.07M
XTNT annual cash flow from financing activities is $16.07 million

Cash from financing 1-year change

-18.37%
XTNT annual cash flow from financing activities is down -18.37% year-on-year

CAPEX

CAPEX

$4.11M
XTNT annual capital expenditures is $4.11 million

CAPEX 1-year change

+182.49%
XTNT annual capital expenditures is up +182.49% year-on-year

Free Cash Flow

Free cash flow

-$16.01M
XTNT annual free cash flow is -$16.01 million

Free cash flow 1-year change

-45.92%
XTNT annual free cash flow is down -45.92% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

58.17%
XTNT annual gross profit margin is 58.17%

Operating margin

-10.30%
XTNT annual operating profit margin is -10.30%

Net margin

-14.03%
XTNT annual net profit margin is -14.03%

ROA & ROE

ROA

-17.64%
XTNT annual return on assets is -17.64%

ROE

-34.88%
XTNT annual return on equity is -34.88%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
XTNT price to earnings ratio value is unknown

PE ratio Sector rank

-
XTNT price to earnings ratio is unknown

PB Ratio

PB ratio

1.28
XTNT price to book ratio is 1.28

PB ratio Sector rank

50.7%
XTNT price to book ratio is higher than 50.7% of companies in Healthcare sector

PS Ratio

PS ratio

0.47
XTNT price to sales ratio is 0.47

PS ratio Sector rank

16.79%
XTNT price to sales ratio is higher than 16.79% of companies in Healthcare sector

Enterprise value

Enterprise value

$83.88M
XTNT enterprise value is $83.88 million

Enterprise value Sector rank

47.73%
XTNT enterprise value is higher than 47.73% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-10.65
XTNT EV/EBITDA is -10.65

EV/EBITDA Sector rank

10.27%
XTNT EV/EBITDA is higher than 10.27% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

2.35
XTNT annual current ratio is 2.35

Quick ratio

1.00
XTNT annual quick ratio is 1.00

Leverage

Debt to equity

0.80
XTNT annual debt to equity ratio is 0.80

Interest coverage ratio

-2.91
XTNT annual interest coverage ratio is -2.91

Risk & Stability

Piotroski F-Score

2
XTNT piotroski f-score is 2

Altman Z-Score

-1.91
XTNT altman z-score is -1.91

Analyst ratings

Recent major analysts updates

May 16, 24 BTIG
Buy
Dec 5, 23 BTIG
Buy
Jul 11, 23 Craig-Hallum
Buy
Apr 26, 23 Craig-Hallum
Buy
May 17, 19 Maxim Group
Hold
Dec 8, 16 Maxim Group
Buy
Nov 30, 16 Aegis Capital
Buy

Institutional Ownership

Similar stocks

HYPR logo
Hyperfine (HYPR)
PMVP logo
PMV Pharmaceuticals (PMVP)
NTRB logo
Nutriband (NTRB)
Cibus (CBUS)
OWLT logo
Owlet (OWLT)
IKNA logo
Ikena Oncology (IKNA)
NEUE logo
NeueHealth (NEUE)
SKYE logo
Skye Bioscience (SKYE)
KRON logo
Kronos Bio (KRON)
  • What is the ticker symbol for Xtant Medical Holdings?
  • Does Xtant Medical Holdings pay dividends?
  • What sector is Xtant Medical Holdings in?
  • What industry is Xtant Medical Holdings in?
  • What country is Xtant Medical Holdings based in?
  • When did Xtant Medical Holdings go public?
  • Is Xtant Medical Holdings in the S&P 500?
  • Is Xtant Medical Holdings in the NASDAQ 100?
  • Is Xtant Medical Holdings in the Dow Jones?
  • When was Xtant Medical Holdings's last earnings report?
  • When does Xtant Medical Holdings report earnings?
  • Should I buy Xtant Medical Holdings stock now?

What is the ticker symbol for Xtant Medical Holdings?

The ticker symbol for Xtant Medical Holdings is NYSE American:XTNT

Does Xtant Medical Holdings pay dividends?

No, Xtant Medical Holdings does not pay dividends

What sector is Xtant Medical Holdings in?

Xtant Medical Holdings is in the Healthcare sector

What industry is Xtant Medical Holdings in?

Xtant Medical Holdings is in the Medical Devices industry

What country is Xtant Medical Holdings based in?

Xtant Medical Holdings is headquartered in United States

When did Xtant Medical Holdings go public?

Xtant Medical Holdings's initial public offering (IPO) was on July 1, 2010

Is Xtant Medical Holdings in the S&P 500?

No, Xtant Medical Holdings is not included in the S&P 500 index

Is Xtant Medical Holdings in the NASDAQ 100?

No, Xtant Medical Holdings is not included in the NASDAQ 100 index

Is Xtant Medical Holdings in the Dow Jones?

No, Xtant Medical Holdings is not included in the Dow Jones index

When was Xtant Medical Holdings's last earnings report?

Xtant Medical Holdings's most recent earnings report was on Mar 6, 2025

When does Xtant Medical Holdings report earnings?

The next expected earnings date for Xtant Medical Holdings is May 15, 2025

Should I buy Xtant Medical Holdings stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page